Cargando…
Increased acetylation of H3K14 in the genomic regions that encode trained immunity enzymes in lysophosphatidylcholine-activated human aortic endothelial cells – Novel qualification markers for chronic disease risk factors and conditional DAMPs
To test our hypothesis that proatherogenic lysophosphatidylcholine (LPC) upregulates trained immunity pathways (TIPs) in human aortic endothelial cells (HAECs), we conducted an intensive analyses on our RNA-Seq data and histone 3 lysine 14 acetylation (H3K14ac)-CHIP-Seq data, both performed on HAEC...
Autores principales: | Lu, Yifan, Sun, Yu, Drummer, Charles, Nanayakkara, Gayani K., Shao, Ying, Saaoud, Fatma, Johnson, Candice, Zhang, Ruijing, Yu, Daohai, Li, Xinyuan, Yang, William Y., Yu, Jun, Jiang, Xiaohua, Choi, Eric T., Wang, Hong, Yang, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543097/ https://www.ncbi.nlm.nih.gov/pubmed/31153039 http://dx.doi.org/10.1016/j.redox.2019.101221 |
Ejemplares similares
-
Procaspase-1 patrolled to the nucleus of proatherogenic lipid LPC-activated human aortic endothelial cells induces ROS promoter CYP1B1 and strong inflammation
por: Lu, Yifan, et al.
Publicado: (2021) -
A Novel Subset of CD95(+) Pro-Inflammatory Macrophages Overcome miR155 Deficiency and May Serve as a Switch From Metabolically Healthy Obesity to Metabolically Unhealthy Obesity
por: Johnson, Candice, et al.
Publicado: (2021) -
Ultrasound May Suppress Tumor Growth, Inhibit Inflammation, and Establish Tolerogenesis by Remodeling Innatome via Pathways of ROS, Immune Checkpoints, Cytokines, and Trained Immunity/Tolerance
por: Yang, Qian, et al.
Publicado: (2021) -
Endothelial Immunity Trained by Coronavirus Infections, DAMP Stimulations and Regulated by Anti-Oxidant NRF2 May Contribute to Inflammations, Myelopoiesis, COVID-19 Cytokine Storms and Thromboembolism
por: Shao, Ying, et al.
Publicado: (2021) -
End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression
por: Zhang, Ruijing, et al.
Publicado: (2020)